Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Research Support, Non-U.S. Gov't"
topic_facet:"Markov model"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Research+Support%2C+Non-U.S.+Gov%27t%22&filter%5B%5D=topic_facet%3A%22Markov+model%22&lookfor=%22Peng%2C+Ye%22&type=Person
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Research+Support%2C+Non-U.S.+Gov%27t%22&filter%5B%5D=topic_facet%3A%22Markov+model%22&lookfor=%22Peng%2C+Ye%22&type=Person
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Research+Support%2C+Non-U.S.+Gov%27t%22&filter%5B%5D=topic_facet%3A%22Markov+model%22&lookfor=%22Peng%2C+Ye%22&type=Person
PubPharm (8)
1
Cost-Effectiveness Analysis of Trastuzumab Deruxtecan versus Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer in the USA
enthalten in:
Advances in therapy
| 2022
von
Wang, J.
|
Yi, Y.
|
Wan, X.
| +3
Wird geladen...
2
Cost-Effectiveness of Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma in the United States
enthalten in:
Advances in therapy
| 2021
von
Peng, Y.
|
She, Z.
|
Peng, L.
| +8
Wird geladen...
3
Cost-Effectiveness of Nivolumab Plus Ipilimumab Combined with Two Cycles of Chemotherapy as First-Line Treatment in Advanced Non-Small Cell Lung Cancer
enthalten in:
Advances in therapy
| 2021
von
Peng, Y.
|
Zeng, X.
|
Peng, L.
| +8
Wird geladen...
4
Cost-Effectiveness of Atezolizumab Plus Chemotherapy as First-Line Therapy for Metastatic Urothelial Cancer
enthalten in:
Advances in therapy
| 2021
von
Qin, S.
|
Yi, L.
|
Li, S.
| +5
Wird geladen...
5
First-Line Atezolizumab for Metastatic NSCLC with High PD-L1 Expression : A United States-Based Cost-Effectiveness Analysis
enthalten in:
Advances in therapy
| 2021
von
Peng, Y.
|
Zeng, X.
|
Peng, L.
| +8
Wird geladen...
6
Cost-Effectiveness Analysis of Adding Daratumumab to a Regimen of Bortezomib, Melphalan, and Prednisone in Newly Diagnosed Multiple Myeloma
enthalten in:
Advances in therapy
| 2021
von
Zeng, X.
|
Liu, Q.
|
Peng, L.
| +6
Wird geladen...
7
Economic Evaluation of Adding Daratumumab to a Regimen of Bortezomib + Dexamethasone in Relapsed or Refractory Multiple Myeloma : Based on the Latest Updated Analysis of CASTOR
enthalten in:
Clinical therapeutics
| 2020
von
Zeng, X.
|
Peng, L.
|
Peng, Y.
| +2
Wird geladen...
8
Model-Based Economic Evaluation of Ceritinib and Platinum-Based Chemotherapy as First-Line Treatments for Advanced Non-Small Cell Lung Cancer in China
enthalten in:
Advances in therapy
| 2019
von
Peng, Y.
|
Ma, F.
|
Tan, C.
| +4
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Research Support, Non-U.S. Gov't
Filter aufheben
Thema: Markov model
Medienart
8
Aufsätze
8
E-Artikel
8
E-Ressourcen
Zeitschriftentitel
7
Advances in therapy
1
Clinical therapeutics
Thema
8
Journal Article
Markov model
Research Support, Non-U.S. Gov't
7
Cost-effectiveness
3
Antibodies, Monoclonal, Humanized
2
4Z63YK6E0E
2
52CMI0WC3Y
2
69G8BD63PP
2
Antibodies, Monoclonal
2
Atezolizumab
2
Bortezomib
2
Daratumumab
2
Multiple myeloma
2
Urothelial carcinoma
2
atezolizumab
2
daratumumab
1
31YO63LBSN
1
49DFR088MY
1
5384HK7574
1
7S5I7G3JQL
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
7
2020-
1
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
8
Englisch
Haven't found what you're looking for?
Wird geladen...